# Trazodone/Gabapentin Fixed Dose Combination Products in Painful Diabetic Neuropathy

> **NCT03749642** · PHASE2 · COMPLETED · sponsor: **Aziende Chimiche Riunite Angelini Francesco S.p.A** · enrollment: 240 (actual)

## Conditions studied

- Painful Diabetic Neuropathy

## Interventions

- **DRUG:** trazodone/gabapentin 2.5/25 mg
- **DRUG:** trazodone/gabapentin 5/50 mg
- **DRUG:** trazodone/gabapentin 10/100
- **DRUG:** Gabapentin
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03749642
- **Lead sponsor:** Aziende Chimiche Riunite Angelini Francesco S.p.A
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-22
- **Primary completion:** 2020-06-06
- **Final completion:** 2020-06-06
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2021-05-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03749642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03749642, "Trazodone/Gabapentin Fixed Dose Combination Products in Painful Diabetic Neuropathy". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT03749642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*